LCN2 and lung cancer: Biochemical analysis showed that lung cancer cachexia model mice treated with anti-LCN2 antibody had significantly lower Fe2+ and MDA concentrations in their eWAT, iWAT, and Gast than those in controls (Fig. 6K, L).